Cited by 2Schizophrenia research and treatmentMental Health Treatment and AccessMental Health and Psychiatry

Psychopathological profile and antipsychotic treatment may be linked to internalised stigma in schizophrenia – a cross-sectional study

Open access
Rodak, Juliusz, Witusik, Andrzej, Nowakowska-Domagała, Katarzyna, Pietras, Tadeusz, Mokros, Łukasz·2018·Postępy Psychiatrii i Neurologii

Abstract

Purpose: The aim of this study was to assess the relationship between the internalised stigma of mental illness associated with the use of antipsychotic treatment and psychopathological profile among patients diagnosed with schizophrenia.Method: The study group comprised 64 patients diagnosed with schizophrenia.The Internalised Stigma of Mental Illness Inventory was used to assess the degree of self-stigmatisation in five aspects: Alienation, Stereotype Endorsement, Discrimination experience, Social withdrawal and Stigma resistance.The symptoms were assessed by a psychiatrist using the Clinical Assessment of Schizophrenic Syndromes Scale.Other variables of interest included data on current pharmacotherapy, body-mass index (BMI) and general functioning.Multivariate linear regression models were created to assess the association between variables of interest and ISMI subscale scores.Results were considered statistically significant when p < 0.05.Results: Zuclopenthixol, a long-acting injectable (LAI), was linked to greater Alienation, Stereotype endorsement and Discrimination experience, while risperidone LAI was associated with higher indices of Stereotype endorsement.Oral risperidone was linked to lower severity of Alienation and a greater level of Stigma resistance.A rise in the Lack of insight score predicted falls in Alienation, Stereotype endorsement, Discrimination experience and Social withdrawal scores.A rise in the Disturbances of Sense of Self score predicted rises in Alienation, Stereotype endorsement and Discrimination experience.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5114/ppn.2018.77034

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Antipsychotic medication may damage the self-concept, with self-doubt, low self-esteem, and self-stigmatization contributing to poor subjective quality of life.

    “Furthermore, antipsychotic medication may damage the self-concept, with self-doubt, low self-esteem, and self-stigmatization contributing to poor subjective quality of life in individuals prescribed antipsychotic medication (Chou et al., 2014; Moritz et al., 2010; Rodak et al., 2018; Sajatovic & Jenkins, 2007).”

    From Narrative identity in the psychosis spectrum: A systematic review and developmental model (2021) · cites this paper as Rodak et al., 2018

    The Abstract reports associations between particular antipsychotics and internalised stigma in patients with schizophrenia, and the Introduction links internalised stigma with low self-esteem and quality of life. Neither passage establishes that medication damages self-concept or produces self-doubt; the Discussion explicitly says the cross-sectional study cannot establish causation. Page numbers were not available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Koschorke M, Evans-Lacko S, Sartorius N, Thornicroft G. Stigma in Different Cultures. In: Gaebel W, Rössler W, Sartorius N (eds.). The Stigma of Mental Illness -End of the Story? Springer International Publishing; 2017, p. 67-82.
  2. Overton SL, Medina SL. The stigma of mental illness. J Couns Dev [Internet] 2008; 86: 143-151. Available at: http://csaweb114v.csa.com/ids70/view_record.php?id=3&recnum=44&log=from_res&SID=ri1jvtea458bjc3et- t7ltb9mr0&mark_id=search:3:81,25,50.
  3. Biernat M, Dovidio JN. Piętno i stereotypy. In: Heatherton TF, Kleck RE, Hebl MR, Hull JG (eds.). Społeczna psychologia piętna. Wydawnictwo Naukowe PWN; 2008, p. 95-125.
  4. Angermeyer MC, Matschinger H. The stereotype of schizophrenia and its impact on discrimination against people with schizophrenia: results from a representative survey in Germany. Schizophr Bull 2004; 30: 1049-1061.
  5. Corrigan P, Watson AMYC. Understanding the impact of stigma on people with mental illness. World Psychia- try [Internet] 2002; 1: 16-20. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489832/.
  6. Chan RCH, Mak WWS. Common sense model of mental illness: Understanding the impact of cognitive and emotional representations of mental illness on recovery through the mediation of self-stigma. Psychiatry Res [Internet] 2016; 246: 16-24. Available at: http://dx.doi.org/10.1016/j.psychres.2016.09.013. · DOI
  7. Schulze B, Angermeyer MC. Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Soc Sci Med [Internet] 2003; 56: 299-312. Available at: http://www.sciencedirect.com/science/article/pii/S027795360200028X.
  8. Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: A systematic review and meta-analysis. Soc Sci Med [Internet] 2010; 71: 2150-2161. Available at: http://dx.doi.org/10.1016/j.socscimed.2010.09.030. · DOI · Paper page
  9. Świtaj P, Grygiel P, Chrostek A, Nowak I, Wciórka J, Anczewska M. The relationship between internalized stigma and quality of life among people with mental illness: are self-esteem and sense of coherence sequential mediators? Qual Life Res [Internet] 2017 May: 1-8. Available at: http://link.springer.com/10.1007/s11136- 017-1596-3. · DOI
  10. Yanos PT, Roe D, Markus K, Lysaker PH. Pathways Between Internalized Stigma and Outcomes Related to Re- covery in Schizophrenia Spectrum Disorders. Psychiatr Serv [Internet] 2008 Dec 1; 59: 1437-1442. Available at: http://ps.psychiatryonline.org/doi/abs/10.1176/ps.2008.59.12.1437. · DOI
  11. Yen C-F, Chen C-C, Lee Y, Tang T-C, Yen J-Y, Ko C-H. Self-Stigma and Its Correlates Among Outpatients With Depressive Disorders. Psychiatr Serv [Internet] 2005 May 1; 56: 599-601. Available at: https://doi.org/10.1176/ appi.ps.56.5.599. · DOI
  12. Mak WW, Wu CF. Cognitive insight and causal attribution in the development of self-stigma among individuals with schizophrenia. Psychiatr Serv [Internet] 2006; 57: 1800-1802. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/17158498%5Cnhttp://psychiatryonline.org/data/Journals/PSS/3785/06ps1800.pdf.
  13. Adewuya AO, Owoeye AO, Erinfolami AO, Ola BA. Correlates of Self-Stigma Among Outpatients With Men- tal Illness in Lagos, Nigeria. Int J Soc Psychiatry [Internet] 2011; 57: 418-427. Available at: http://isp.sagepub. com/content/57/4/418%5Cnhttp://isp.sagepub.com/content/57/4/418.full.pdf%5Cnhttp://isp.sagepub.com/ content/57/4/418.short.
  14. Uhlmann C, Kaehler J, Harris MSH, Unser J, Arolt V, Lencer R. Negative Impact of Self-Stigmatization on Attitude Toward Medication Adherence in Patients with Psychosis. J Psychiatr Pract [Internet] 2014; 20. Available at: https://journals.lww.com/practicalpsychiatry/Fulltext/2014/09000/Negative_Impact_of_Self_Stig- matization_on_Attitude.13.aspx.
  15. Surmann M, Gruchalla L von, Falke S, Maisch B, Uhlmann C, Bock E, et al. The importance of strengthe- ning competence and control beliefs in patients with psychosis to reduce treatment hindering self-stigma- tization. Psychiatry Res [Internet] 2018 Jan 21; 255: 314-320. Available at: http://dx.doi.org/10.1016/j. psychres.2017.05.053. · DOI
  16. Hamann J, Langer B, Leucht S, Busch R, Kissling W. Medical decision making in antipsychotic drug choice for schizophrenia. Am J Psychiatry 2004; 161: 1301-134.
  17. Edlinger M, Hofer A, Rettenbacher MA, Baumgartner S, Widschwendter CG, Kemmler G, et al. Factors influ- encing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia. Schizophr Res [Internet] 2009; 113: 246-251. Available at: http://dx.doi.org/10.1016/j.schres.2009.06.008. · DOI
  18. de Bartolomeis A, Fagiolini A, Vaggi M, Vampini C. Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: Key outcome drivers, role of quality of life, and place of long-acting antipsychotics. Neuro- psychiatr Dis Treat 2016; 12: 99-108.
  19. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of anti- psychotic dosing. Am J Psychiatry 2010; 167: 686-693.
  20. Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: Psychometric properties of a new measure. Psychiatry Res 2003; 121: 31-49.
  21. Boyd JE, Adler EP, Otilingam PG, Peters T. Internalized Stigma of Mental Illness (ISMI) Scale : A multinational review Internalized Stigma of Mental Illness (ISMI) Scale : A multinational review. Compr Psychiatry [Internet] 2014; 55: 221-231. Available at: http://dx.doi.org/10.1016/j.comppsych.2013.06.005. · DOI
  22. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990; 9: 811-818.
  23. Jauhar S, Guloksuz S, Andlauer O, Lydall G, Marques JG, Mendonca L, et al. Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence? BMC Psychiatry [Internet] 2012; 12: 27. Available at: http://bmcpsychiatry.biomedcentral.com/articles/10.1186/1471-244X-12-27. · DOI
  24. Tse WS, Wong ASW, Chan F, Pang AHT, Bond AJ, Chan CKR. Different mechanisms of risperidone result in improved interpersonal trust, social engagement and cooperative behavior in patients with schizophrenia com- pared to trifluoperazine. Psychiatry Clin Neurosci 2016; 70: 218-226.
  25. Koschorke M, Padmavati R, Kumar S, Cohen A, Weiss HA, Chatterjee S, et al. Experiences of stigma and dis- crimination of people with schizophrenia in India. Soc Sci Med [Internet] 2014; 123: 149-159. Available at: http://dx.doi.org/10.1016/j.socscimed.2014.10.035. · DOI
  26. Kamaradova D, Latalova K, Prasko J, Kubinek R, Vrbova K, Mainerova B, et al. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence 2016; 10: 1289-1298.
  27. Picco L, Pang S, Lau YW, Jeyagurunathan A, Satghare P, Abdin E, et al. Internalized stigma among psychiatric outpatients: Associations with quality of life, functioning, hope and self-esteem. Psychiatry Res [Internet] 2016; 246 (May): 500-506. Available at: http://dx.doi.org/10.1016/j.psychres.2016.10.041. · DOI
  28. Shin YJ, Joo YH, Kim JH. Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia. Neuropsychiatr Dis Treat 2016; 12: 1411-1417.
  29. Vrbova K, Prasko J, Holubova M, Kamaradova D, Ociskova M, Marackova M, et al. Self-stigma and schizophre- nia: A cross-sectional study. Neuropsychiatr Dis Treat [Internet] 2016; 12: 3011-3020. Available at: http://ovidsp. ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=psyc13&NEWS=N&AN=2016-58744-001.
  30. Fruh SM, Nadglowski J, Hall HR, Davis SL, Crook ED, Zlomke K. Obesity Stigma and Bias. J Nurse Pract [Inter- net] 2016; 12: 425-432. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386399/.
  31. Barber J, Palmese L, Reutenauer EL, Grilo C, Tek C. Implications of weight-based stigma and self-bias on quality of life among individuals with Schizophrenia. J Nerv Ment Dis [Internet] 2011 Jul; 199: 431-435. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135000/.

Cited by

Sorted by citations

Authors
Rodak, J., Witusik, A., Nowakowska-Domagała, K., Pietras, T., & Mokros, Ł.
Affiliations
  • Jan Kochanowski University (PL)
  • Medical University of Lodz (PL)
Corresponding author
Mokros, Łukasz
Venue
Postępy Psychiatrii i Neurologii
Published
2018
Volume
27
Issue
2
Pages
77-86
ISSN
1230-2813 (ISSN-L)
OpenAlex
W2887922664
Cited by
2
References
7
Citations by year
2021: 1 · 2019: 1
FWCI
0.39
Type
journal article
Language
pl
Open access
Licence
cc-by-nc-nd
Locations
Postępy Psychiatrii i Neurologii (publishedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
schizophrenia, self-stigma, antipsychotic drugs, long-acting injectable antipsychotics, zuclopenthixol, risperidone, alienation, stereotype endorsement, discrimination experiences, stigma resistance, social withdrawal, lack of insight, psychopathological profile

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review